BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Corso G, Pedrazzani C, Pinheiro H, Fernandes E, Marrelli D, Rinnovati A, Pascale V, Seruca R, Oliveira C, Roviello F. E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer. Eur J Cancer. 2011;47:631-639. [PMID: 21106365 DOI: 10.1016/j.ejca.2010.10.011] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Lim HJ, Zhuang L, Fitzgerald RC. Current advances in understanding the molecular profile of hereditary diffuse gastric cancer and its clinical implications. J Exp Clin Cancer Res 2023;42:57. [PMID: 36869400 DOI: 10.1186/s13046-023-02622-3] [Reference Citation Analysis]
2 Massari G, Tagliaferri V, Corso G. Worldwide CDH1 Germline Mutation Frequency. Hereditary Gastric and Breast Cancer Syndrome 2023. [DOI: 10.1007/978-3-031-21317-5_2] [Reference Citation Analysis]
3 Pereira J, Melo S, Carneiro P, Fernandes MS, Figueiredo J, Seruca R. Revisiting the Biological and Clinical Impact of CDH1 Missense Variants. Hereditary Gastric and Breast Cancer Syndrome 2023. [DOI: 10.1007/978-3-031-21317-5_6] [Reference Citation Analysis]
4 Choi YJ, Kim B, Kim Y, Shin S, Lee K. Applying Functional Assay Evidence to Interpret Sequence Variants Identified in Hereditary Cancer Genes. Lab Med Online 2022;12:145-158. [DOI: 10.47429/lmo.2022.12.3.145] [Reference Citation Analysis]
5 Torrejon NV, Deshpande S, Wei W, Tullio K, Kamath SD. Proportion of Early-Onset Gastric and Esophagus Cancers Has Changed Over Time With Disproportionate Impact on Black and Hispanic Patients. JCO Oncol Pract 2022;18:e759-69. [PMID: 35544654 DOI: 10.1200/OP.21.00692] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Zhang J, Bai J, Zhu H, Li W, An Q, Wang D. The upregulation of circFNDC3B aggravates the recurrence after endoscopic submucosal dissection (ESD) in early gastric cancer (EGC) patients. Sci Rep 2022;12:6178. [PMID: 35418175 DOI: 10.1038/s41598-022-07154-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Pan Z, Fu Z, Luo C, Bao Y, Wang M, Cao W, Xu X. CDH1 germline mutations in a Chinese cohort with hereditary diffuse gastric cancer. J Cancer Res Clin Oncol 2021. [PMID: 34537906 DOI: 10.1007/s00432-021-03775-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Huang Q, Zheng X, Jiao Y, Lei Y, Li X, Bi F, Guo F, Wang G, Liu M. A Distinct Clinicopathological Feature and Prognosis of Young Gastric Cancer Patients Aged ≤ 45 Years Old. Front Oncol 2021;11:674224. [PMID: 34513668 DOI: 10.3389/fonc.2021.674224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Businello G, Angerilli V, Parente P, Realdon S, Savarino E, Farinati F, Grillo F, Vanoli A, Galuppini F, Paccagnella S, Pennelli G, Mastracci L, Saragoni L, Fassan M. Molecular Landscapes of Gastric Pre-Neoplastic and Pre-Invasive Lesions. Int J Mol Sci 2021;22:9950. [PMID: 34576114 DOI: 10.3390/ijms22189950] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
10 Zhao H, Hu H, Chen B, Xu W, Zhao J, Huang C, Xing Y, Lv H, Nie C, Wang J, He Y, Wang SQ, Chen XB. Overview on the Role of E-Cadherin in Gastric Cancer: Dysregulation and Clinical Implications. Front Mol Biosci 2021;8:689139. [PMID: 34422902 DOI: 10.3389/fmolb.2021.689139] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
11 Corso G, Corso F, Bellerba F, Carneiro P, Seixas S, Cioffi A, La Vecchia C, Magnoni F, Bonanni B, Veronesi P, Gandini S, Figueiredo J. Geographical Distribution of E-cadherin Germline Mutations in the Context of Diffuse Gastric Cancer: A Systematic Review. Cancers (Basel) 2021;13:1269. [PMID: 33809393 DOI: 10.3390/cancers13061269] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
12 Sarhadi V, Mathew B, Kokkola A, Karla T, Tikkanen M, Rautelin H, Lahti L, Puolakkainen P, Knuutila S. Gut microbiota of patients with different subtypes of gastric cancer and gastrointestinal stromal tumors. Gut Pathog 2021;13:11. [PMID: 33596997 DOI: 10.1186/s13099-021-00403-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
13 Malli IA. From Inflammation to Cancer: Role of Genetic Polymorphisms of Inflammatory Pathway Molecules in Gastric Cancer. Genetic Polymorphism and cancer susceptibility 2021. [DOI: 10.1007/978-981-33-6699-2_4] [Reference Citation Analysis]
14 Liao F, Guo X, Lu X, Dong W. A validated survival nomogram for early-onset diffuse gastric cancer. Aging (Albany NY) 2020;12:13160-71. [PMID: 32639946 DOI: 10.18632/aging.103406] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
15 Corso G, Roviello F. Germline mutations of the E-cadherin gene (CDH1) in early onset gastric cancer. Semin Oncol 2020;47:125-6. [PMID: 32416945 DOI: 10.1053/j.seminoncol.2020.04.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Wang SC, Yeu Y, Hammer STG, Xiao S, Zhu M, Hong C, Clemenceau JR, Yoon LY, Nassour I, Shen J, Agarwal D, Reznik SI, Mansour JC, Yopp AC, Zhu H, Hwang TH, Porembka MR. Hispanic/Latino Patients with Gastric Adenocarcinoma Have Distinct Molecular Profiles Including a High Rate of Germline CDH1 Variants. Cancer Res 2020;80:2114-24. [PMID: 32269045 DOI: 10.1158/0008-5472.CAN-19-2918] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
17 Choi S, Jang J, Heo YJ, Kang SY, Kim ST, Lee J, Kang WK, Kim JW, Kim KM. CDH1 mutations in gastric cancers are not associated with family history. Pathol Res Pract 2020;216:152941. [PMID: 32241597 DOI: 10.1016/j.prp.2020.152941] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
18 Moridnia A, Tabatabaiefar MA, Zeinalian M, Minakari M, Kheirollahi M, Moghaddam NA. Novel Variants and Copy Number Variation in CDH1 Gene in Iranian Patients with Sporadic Diffuse Gastric Cancer. J Gastrointest Cancer 2019;50:420-7. [PMID: 29577179 DOI: 10.1007/s12029-018-0082-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
19 Guindalini RSC, Cormedi MCV, Maistro S, Pasini FS, Branas PCAA, Dos Santos L, de Lima Pereira GF, de Bock GH, Saccaro DM, Katayama MLH, Faraj SF, Safatle-Ribeiro A, Ribeiro Junior U, Diz MDPE, de Gouvêa ACRC, Chammas R, Folgueira MAAK. Frequency of CDH1 germline variants and contribution of dietary habits in early age onset gastric cancer patients in Brazil. Gastric Cancer 2019;22:920-31. [PMID: 30895400 DOI: 10.1007/s10120-019-00945-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
20 Guan WL, Yuan LP, Yan XL, Yang DJ, Qiu MZ. More attention should be paid to adult gastric cancer patients younger than 35 years old: extremely poor prognosis was found. J Cancer. 2019;10:472-478. [PMID: 30719142 DOI: 10.7150/jca.27517] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
21 Luo W, Fedda F, Lynch P, Tan D. CDH1 Gene and Hereditary Diffuse Gastric Cancer Syndrome: Molecular and Histological Alterations and Implications for Diagnosis And Treatment. Front Pharmacol. 2018;9:1421. [PMID: 30568591 DOI: 10.3389/fphar.2018.01421] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 8.4] [Reference Citation Analysis]
22 Corso G, De Scalzi A, Feroce I, Veronesi P, Bonanni B, Galimberti V. Clinical criteria revision for hereditary lobular breast cancer associated with E-cadherin germline mutations. Per Med 2018;15:153-5. [PMID: 29745790 DOI: 10.2217/pme-2017-0083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
23 GE4GAC group. Genomics and epidemiology for gastric adenocarcinomas. Appl Cancer Res 2017;37. [DOI: 10.1186/s41241-017-0011-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
24 Yu J, Zheng W. An Alternative Method for Screening Gastric Cancer Based on Serum Levels of CEA, CA19-9, and CA72-4. J Gastrointest Canc 2018;49:57-62. [DOI: 10.1007/s12029-016-9912-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
25 Baniak N, Senger JL, Ahmed S, Kanthan SC, Kanthan R. Gastric biomarkers: a global review. World J Surg Oncol. 2016;14:212. [PMID: 27514667 DOI: 10.1186/s12957-016-0969-3] [Cited by in Crossref: 67] [Cited by in F6Publishing: 72] [Article Influence: 9.6] [Reference Citation Analysis]
26 Ma J, Shen H, Kapesa L, Zeng S. Lauren classification and individualized chemotherapy in gastric cancer. Oncol Lett. 2016;11:2959-2964. [PMID: 27123046 DOI: 10.3892/ol.2016.4337] [Cited by in Crossref: 108] [Cited by in F6Publishing: 116] [Article Influence: 15.4] [Reference Citation Analysis]
27 Zhou F, Shi J, Fang C, Zou X, Huang Q. Gastric Carcinomas in Young (Younger than 40 Years) Chinese Patients: Clinicopathology, Family History, and Postresection Survival. Medicine (Baltimore) 2016;95:e2873. [PMID: 26945372 DOI: 10.1097/MD.0000000000002873] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
28 Sandoval-Bórquez A, Saavedra K, Carrasco-Avino G, Garcia-Bloj B, Fry J, Wichmann I, Corvalán AH. Noncoding Genomics in Gastric Cancer and the Gastric Precancerous Cascade: Pathogenesis and Biomarkers. Dis Markers 2015;2015:503762. [PMID: 26379360 DOI: 10.1155/2015/503762] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
29 Sugimoto S, Komatsu H, Morohoshi Y, Kanai T. Recognition of and recent issues in hereditary diffuse gastric cancer. J Gastroenterol 2015;50:831-43. [PMID: 26049741 DOI: 10.1007/s00535-015-1093-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
30 Corso G, Figueiredo J, Biffi R, Trentin C, Bonanni B, Feroce I, Serrano D, Cassano E, Annibale B, Melo S, Seruca R, De Lorenzi F, Ferrara F, Piagnerelli R, Roviello F, Galimberti V. E-cadherin germline mutation carriers: clinical management and genetic implications. Cancer Metastasis Rev 2014;33:1081-94. [PMID: 25332147 DOI: 10.1007/s10555-014-9528-y] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
31 Moreira-Nunes CA, Barros MBL, do Nascimento Borges B, Montenegro RC, Lamarão LM, Ribeiro HF, Bona AB, Assumpção PP, Rey JA, Pinto GR, Burbano RR. Genetic screening analysis of patients with hereditary diffuse gastric cancer from northern and northeastern Brazil. Hered Cancer Clin Pract 2014;12:18. [PMID: 25180051 DOI: 10.1186/1897-4287-12-18] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
32 Kim S, Chung JW, Jeong TD, Park YS, Lee JH, Ahn JY, Kim DH, Choi KD, Lee W, Song HJ, Lee GH, Chun S, Jung HY, Min WK, Kim JH. Searching for E-cadherin gene mutations in early onset diffuse gastric cancer and hereditary diffuse gastric cancer in Korean patients. Fam Cancer 2013;12:503-7. [PMID: 23264079 DOI: 10.1007/s10689-012-9595-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
33 Lee YS, Cho YS, Lee GK, Lee S, Kim YW, Jho S, Kim HM, Hong SH, Hwang JA, Kim SY. Genomic profile analysis of diffuse-type gastric cancers. Genome Biol. 2014;15:R55. [PMID: 24690483 DOI: 10.1186/gb-2014-15-4-r55] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 5.6] [Reference Citation Analysis]
34 Molinaro V, Pensotti V, Marabelli M, Feroce I, Barile M, Pozzi S, Laghi L, Serrano D, Bernard L, Bonanni B, Ranzani GN. Complementary molecular approaches reveal heterogeneous CDH1 germline defects in Italian patients with hereditary diffuse gastric cancer (HDGC) syndrome. Genes Chromosomes Cancer 2014;53:432-45. [PMID: 24493355 DOI: 10.1002/gcc.22155] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
35 Bordeira-Carriço R, Ferreira D, Mateus DD, Pinheiro H, Pêgo AP, Santos MA, Oliveira C. Rescue of wild-type E-cadherin expression from nonsense-mutated cancer cells by a suppressor-tRNA. Eur J Hum Genet 2014;22:1085-92. [PMID: 24424122 DOI: 10.1038/ejhg.2013.292] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
36 Sugimoto S, Yamada H, Takahashi M, Morohoshi Y, Yamaguchi N, Tsunoda Y, Hayashi H, Sugimura H, Komatsu H. Early-onset diffuse gastric cancer associated with a de novo large genomic deletion of CDH1 gene. Gastric Cancer 2014;17:745-9. [PMID: 23812922 DOI: 10.1007/s10120-013-0278-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
37 Garziera M, Canzonieri V, Cannizzaro R, Geremia S, Caggiari L, De Zorzi M, Maiero S, Orzes E, Perin T, Zanussi S, De Paoli P, De Re V. Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer. PLoS One 2013;8:e77035. [PMID: 24204729 DOI: 10.1371/journal.pone.0077035] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
38 He C, Chen M, Liu J, Yuan Y. Host genetic factors respond to pathogenic step-specific virulence factors of Helicobacter pylori in gastric carcinogenesis. Mutat Res Rev Mutat Res. 2014;759:14-26. [PMID: 24076409 DOI: 10.1016/j.mrrev.2013.09.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
39 Uppal DS, Powell SM. Genetics/genomics/proteomics of gastric adenocarcinoma. Gastroenterol Clin North Am 2013;42:241-60. [PMID: 23639639 DOI: 10.1016/j.gtc.2013.01.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
40 Yakirevich E, Resnick MB. Pathology of gastric cancer and its precursor lesions. Gastroenterol Clin North Am 2013;42:261-84. [PMID: 23639640 DOI: 10.1016/j.gtc.2013.01.004] [Cited by in Crossref: 99] [Cited by in F6Publishing: 102] [Article Influence: 9.9] [Reference Citation Analysis]
41 Oliveira C, Seruca R, Hoogerbrugge N, Ligtenberg M, Carneiro F. Clinical utility gene card for: Hereditary diffuse gastric cancer (HDGC). Eur J Hum Genet. 2013;21. [PMID: 23443028 DOI: 10.1038/ejhg.2012.247] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
42 Tobias ES. The Molecular Biology of Cancer. Emery and Rimoin's Principles and Practice of Medical Genetics 2013. [DOI: 10.1016/b978-0-12-383834-6.00021-5] [Reference Citation Analysis]
43 Carvalho J, Pinheiro H, Oliveira C. E-Cadherin Germline Mutations. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
44 Corso G, Marrelli D, Roviello F. Clinical Management of Familial Gastric Cancer. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_16] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
45 Carneiro F, Oliveira C, Seruca R. Hereditary Diffuse Gastric Cancer and Other Gastric Cancers Associated with Hereditary Predisposition Syndromes. Molecular Pathology Library 2013. [DOI: 10.1007/978-1-4614-6015-2_6] [Reference Citation Analysis]
46 Corso G. Appendix. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_17] [Reference Citation Analysis]
47 Oliveira C, Pinheiro H, Figueiredo J, Seruca R, Carneiro F. E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer. Prog Mol Biol Transl Sci 2013;116:337-59. [PMID: 23481202 DOI: 10.1016/B978-0-12-394311-8.00015-7] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 4.5] [Reference Citation Analysis]
48 Garcea D, Rinnovati A, Morgagni P. Gastric Malignancies. What’s New in Surgical Oncology 2013. [DOI: 10.1007/978-88-470-5310-6_2] [Reference Citation Analysis]
49 Corso G, Roncalli F, Marrelli D, Carneiro F, Roviello F. History, pathogenesis, and management of familial gastric cancer: original study of John XXIII's family. Biomed Res Int 2013;2013:385132. [PMID: 23484115 DOI: 10.1155/2013/385132] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
50 Vogelaar IP, van der Post RS, Bisseling TM, van Krieken JHJ, Ligtenberg MJ, Hoogerbrugge N. Familial gastric cancer: detection of a hereditary cause helps to understand its etiology. Hered Cancer Clin Pract 2012;10:18. [PMID: 23231819 DOI: 10.1186/1897-4287-10-18] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
51 Medvetz DA, Khabibullin D, Hariharan V, Ongusaha PP, Goncharova EA, Schlechter T, Darling TN, Hofmann I, Krymskaya VP, Liao JK, Huang H, Henske EP. Folliculin, the product of the Birt-Hogg-Dube tumor suppressor gene, interacts with the adherens junction protein p0071 to regulate cell-cell adhesion. PLoS One 2012;7:e47842. [PMID: 23139756 DOI: 10.1371/journal.pone.0047842] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 5.4] [Reference Citation Analysis]
52 Carneiro P, Fernandes MS, Figueiredo J, Caldeira J, Carvalho J, Pinheiro H, Leite M, Melo S, Oliveira P, Simões-Correia J, Oliveira MJ, Carneiro F, Figueiredo C, Paredes J, Oliveira C, Seruca R. E-cadherin dysfunction in gastric cancer--cellular consequences, clinical applications and open questions. FEBS Lett 2012;586:2981-9. [PMID: 22841718 DOI: 10.1016/j.febslet.2012.07.045] [Cited by in Crossref: 64] [Cited by in F6Publishing: 72] [Article Influence: 5.8] [Reference Citation Analysis]
53 Garziera M, De Re V, Geremia S, Seruca R, Figueiredo J, Melo S, Simões-Correia J, Caggiari L, De Zorzi M, Canzonieri V, Cannizzaro R, Toffoli G. A novel CDH1 germline missense mutation in a sporadic gastric cancer patient in north-east of Italy. Clin Exp Med 2013;13:149-57. [PMID: 22543498 DOI: 10.1007/s10238-012-0184-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
54 Corso G, Marrelli D, Pascale V, Vindigni C, Roviello F. Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature. BMC Cancer. 2012;12:8. [PMID: 22225527 DOI: 10.1186/1471-2407-12-8] [Cited by in Crossref: 65] [Cited by in F6Publishing: 70] [Article Influence: 5.9] [Reference Citation Analysis]
55 Corso G, Marrelli D, Roviello F. Etiopathogenesis of Gastric Cancer. Surgery in the Multimodal Management of Gastric Cancer 2012. [DOI: 10.1007/978-88-470-2318-5_2] [Reference Citation Analysis]
56 Deng CS. Advances in research and diagnosis of early gastric cancer. Shijie Huaren Xiaohua Zazhi 2011; 19(32): 3309-3312 [DOI: 10.11569/wcjd.v19.i32.3309] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
57 de Vries AC, Kuipers EJ. Gastric cancer in young patients: clues on a possible separate entity requiring a watchful approach. J Gastroenterol Hepatol 2011;26:1581-2. [PMID: 22011292 DOI: 10.1111/j.1440-1746.2011.06902.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
58 Corso G, Marrelli D, Roviello F. Familial gastric cancer: update for practice management. Fam Cancer 2011;10:391-6. [PMID: 21184285 DOI: 10.1007/s10689-010-9410-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
59 Shah MA, Salo-Mullen E, Stadler Z, Ruggeri JM, Mirander M, Pristyazhnyuk Y, Zhang L. De novo CDH1 mutation in a family presenting with early-onset diffuse gastric cancer. Clin Genet. 2012;82:283-287. [PMID: 21696387 DOI: 10.1111/j.1399-0004.2011.01744.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
60 [DOI: 10.1101/764779] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]